• Aucun résultat trouvé

[PDF] Top 20 Celiac axis infusion chemotherapy in advanced nonresectable pancreatic cancer

Has 10000 "Celiac axis infusion chemotherapy in advanced nonresectable pancreatic cancer" found on our website. Below are the top 20 most common "Celiac axis infusion chemotherapy in advanced nonresectable pancreatic cancer".

Celiac axis infusion chemotherapy in advanced nonresectable pancreatic cancer

Celiac axis infusion chemotherapy in advanced nonresectable pancreatic cancer

... From May 1994 to February 1995, 12 consecutive patients with biopsy-proven advanced ductal carcinoma of the exocrine pancreas were given intra-arterial infusions consisting of Mitoxant[r] ... Voir le document complet

6

P-0127MULTIMODALITY TREATMENT APPROACH FOR LOCALLY ADVANCED PANCREATIC CANCER

P-0127MULTIMODALITY TREATMENT APPROACH FOR LOCALLY ADVANCED PANCREATIC CANCER

... Design Pancreatic cancer resectability is defined by the absence of metastases and only limited invasion of arteries (SMA, common hepatic artery, celiac trunk) and veins (superior mesenteric vein / ... Voir le document complet

1

Activity of raltitrexed and gemcitabine in advanced pancreatic cancer

Activity of raltitrexed and gemcitabine in advanced pancreatic cancer

... benefit in patients undergoing treatment with the combination gemcitabine plus continuous-infusion 5-FU [3, ...gemcitabine in advanced pancreatic ...underdosed in this study ... Voir le document complet

6

Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma

Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma

... NAC in this cohort was based on evidence of nodal involvement at cross-sectional ...imaging. In our cohort, patients with advanced clinical stage ( ≥cT3 and/or cN+) were more likely to undergo ... Voir le document complet

6

Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis

Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis

... was in the range of €7 538–€10 836 and suggested favorable ...cetuximab in colorectal and head and neck cancer might not be the only reason for a higher cost-effectiveness compared with the NSCLC ... Voir le document complet

8

Docetaxel-based chemotherapy in the treatment of gastric cancer

Docetaxel-based chemotherapy in the treatment of gastric cancer

... forms. In Italy, there was an attempt to intensify treat- ment, using growth factor support, by adopting a weekly ...schedule. In the ECF (epirubicin/cisplatin/5-FU) regimen, 5-FU is given by protracted ... Voir le document complet

4

Celiac disease in the Mediterranean area.

Celiac disease in the Mediterranean area.

... experience in CD ...UI, in combination with EMA dilution titer ≥1:160, had a positive predictive value of 83% for ...that in diabetic patients high tTG titres predict a diagnosis of CD, when ... Voir le document complet

8

Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study.

Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study.

... achieved in 10 patients in arm A (34.5%; 95% CI: 17.2% to 51.8%) and in 9 patients ...49.4%) in arm ...observed in the control group in comparison with the experimental ... Voir le document complet

6

Chemotherapy in gastric cancer: a never ending saga

Chemotherapy in gastric cancer: a never ending saga

... trial in gastric ...cisplatin in advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative ... Voir le document complet

3

Relation between polymorphisms and chemotherapy in lung cancer

Relation between polymorphisms and chemotherapy in lung cancer

... present in tropical and subtropical regions, including Miyako Island, Okinawa, ...used in various folk medicines and as a popular ingredient in herbal tea for its anti-inflammatory, anti-septic, ... Voir le document complet

2

Molekulare Veränderungen beim Pankreaskarzinom
			
			  
			    = Molecular alterations in pancreatic cancer

Molekulare Veränderungen beim Pankreaskarzinom = Molecular alterations in pancreatic cancer

... Kobrin MS, Btichler M, Beget HG, Korc M: Coexpres- sion of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness.. Ko[r] ... Voir le document complet

3

Extended Lymphadenectomy in Patients With Pancreatic Cancer Is Debatable

Extended Lymphadenectomy in Patients With Pancreatic Cancer Is Debatable

... factors in determining the prognosis after resection of pancreatic ductal ...lymphadenectomy in patients with adenocarcinoma of the corpus and ... Voir le document complet

7

Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer

Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer

... https://doi.org/10.1007/s10456-014-9422-9 Access and use of this website and the material on it are subject to the Terms and Conditions set forth at Analysis of acquired resistance to metronomic oral topotecan ... Voir le document complet

32

Optimizing circadian drug infusion schedules towards personalized cancer chronotherapy

Optimizing circadian drug infusion schedules towards personalized cancer chronotherapy

... differences in maximum plasma drug concentrations and in the time at which it occurred led us to further investigate variability in between ...decrease in CVs is not unexpected, but the ... Voir le document complet

27

Botulinum toxin potentiates cancer radiotherapy and chemotherapy

Botulinum toxin potentiates cancer radiotherapy and chemotherapy

... involved in the fusion of vesicles with presynaptic membranes and consequently impedes the release of neurotransmitters, such as acetylcholine and noradrenaline, at the neuromuscular junction (10 ...changes ... Voir le document complet

8

Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis

Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis

... breast cancer is individualized, it seems that the choice of adjuvant treatment in patients with residual disease after NAC should also be personalized and targeted to pathological ...Vinorelbine) in ... Voir le document complet

16

Characterization Of Intestinal Microbiota In Celiac Children

Characterization Of Intestinal Microbiota In Celiac Children

... ABSTRACT Celiac disease (CD) is enteropathy autoimmune induced by the ingestion of gluten in genetically predisposed ...microbiota. In this study, 13 Samples of intestinal biopsy, 15 fecal samples ... Voir le document complet

11

Characterization of the salivary microbiome in patients with pancreatic cancer

Characterization of the salivary microbiome in patients with pancreatic cancer

... community in healthy individuals ( Zaura, Keijser & Huse, 2009 ) and shifts from this core microbiome have been associated with dental carries and periodontitis ( Berezow & Darveau, 2011 ...communities ... Voir le document complet

17

Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study

Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study

... improvement in PDQ-39 20 , 21 , it has been suggested that from a methodological point of view, this scale may intrinsically be more responsive to decline than improve- ment 22 ...HRQoL in PD patients and ... Voir le document complet

12

A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer

A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer

... results in patients with LA and ...for advanced BTC. Keywords: FOLFIRINOX, Advanced biliary tract cancer, Real life practice, Cholangiocarcinoma © The ...reproduction in any medium or ... Voir le document complet

9

Show all 10000 documents...